fbpx
QQQ
+ 0.66
341.60
+ 0.19%
DIA
-0.49
343.90
-0.14%
SPY
-0.31
424.79
-0.07%
TLT
+ 0.12
140.94
+ 0.08%
GLD
-0.27
174.32
-0.16%

FDA: CBD Products Mostly Illegal

December 24, 2018 11:27 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Cannabis stocks were moving lower Monday morning after the Food and Drug Administration suggested hemp-derived cannabidiol, or CBD, is mostly illegal.

What Happened

The farm bill signed by President Donald Trump last week designated hemp as an agricultural crop.

Yet CBD oil is a drug ingredient and cannot be included in products without FDA approval.

"Selling unapproved products with unsubstantiated therapeutic claims is not only a violation of the law, but also can put patients at risk, as these products have not been proven to be safe or effective," FDA Commissioner Scott Gottlieb said in a statement.

Cannabis investors can't miss the Benzinga Cannabis Capital Conference, the No. 1 networking event for institutional capital and the leading cannabis companies. Secure your tickets here before they run out.

Why It's Important

Parts of hemp are already safe as food ingredients in the FDA's view, including hemp seeds, hemp seed protein and hemp seed oil.The FDA said these are safe for use in food products under the condition they are not marketed as a treatment for diseases.

What's Next

Cannabis stocks were trading as follows at the time of publication Monday: 

  • New Age Beverages Corp (NASDAQ:NBEV): down 4.78 percent. 
  • Aphria Inc (NYSE:APHA): up 13.81 percent. 
  • Tilray Inc (NASDAQ:TLRY): down 3.62 percent. 
  • Cronos Group Inc (NASDAQ:CRON): up 1.47 percent. 
  • Aurora Cannabis Inc (NYSE:ACB): up 2.4 percent. 
  • Canopy Growth Corp (NYSE:CGC): up 2.78 percent. 
  • Pyxus International Inc (NYSE:PYX): up 1 percent. 

Related Links:

Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week

Canadian Government Releases Proposed Cannabis Edible Regulations

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Posted-In:

Cannabis News FDA Markets

Related Articles

The Week In Cannabis: Amazon, Canopy's Earnings, Africa's Largest Co., Drake, Ashley Benson And More

Another busy week in cannabis saw the stock market post generalized losses, as Amazon.com Inc. (NASDAQ: AMZN) came out in support of the federal legalization of marijuana, announcing it will drop marijuana testing requirements for some of its workers. read more

The Week In Cannabis: Earnings, Financings, M&A, Cookies U, DEA, DJ Khaled, And More

In an earnings-heavy week, cannabis stocks experienced considerable volatility. read more

Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap. read more

The Week In Cannabis: Trulieve's $2.1B Acquisition, New ETF, Earnings, Federal Legalization And More

In a week of big M&A news and mixed earnings reports, cannabis stocks traded mostly down. read more